Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02961946 · ClinicalTrials.gov registry record · Phase 4
Effects of Sublingual and Transdermal Administration of Nitroglycerin for Coronary CT Angiography on Image Quality
A Phase 4 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 198
- Enrollment target
NCT02961946: Completed Phase 4 study, sponsored by Massachusetts General Hospital.
NCT02961946 is a Phase 4 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 198 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02961946, a Phase 4 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 198 participants
- Enrollment target
Study Summary
To evaluate image quality of coronary CT angiography (cCTA) after sublingual and transdermal administration of Nitroglycerin. Aim of this prospective research study is to investigate equivalence on image quality after sublingual or transdermal Nitroglycerin administration (H0). Furthermore, the feasibility of transdermal Nitroglycerin administration will be evaluated.
Interventions
- DRUG Nitroglycerin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 198 participants |
| Start Date | 2017-03-15 |
| Est. Completion | 2018-08-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02961946
The ClinicalTrials.gov registry entry for NCT02961946 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 198 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nitroglycerin is the first listed.
NCT02961946 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02961946 about?
NCT02961946 is a clinical study titled "Effects of Sublingual and Transdermal Administration of Nitroglycerin for Coronary CT Angiography on Image Quality". To evaluate image quality of coronary CT angiography (cCTA) after sublingual and transdermal administration of Nitroglycerin. Aim of this prospective research study is to investigate equivalence on image quality after sublingual or transdermal Nitroglycerin administration (H0). Furthermore, the fea...
What is the current status of trial NCT02961946?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 198 participants. The study started on 2017-03-15. Estimated completion is 2018-08-02.
What interventions are being tested in trial NCT02961946?
The interventions under investigation include: Nitroglycerin (DRUG).
Who is sponsoring clinical trial NCT02961946?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.